Sul J, Posner JB. Brain metastases: epidemiology and pathophysiology. Cancer Treat Res. 2007;136:1–21.

Article  PubMed  Google Scholar 

Soffietti R, Rudā R, Mutani R. Management of brain metastases. J Neurol. 2002;249:1357–69.

Article  PubMed  Google Scholar 

Kraft J, Zindler J, Minniti G, Guckenberger M, Andratschke N. Stereotactic radiosurgery for multiple brain metastases. Curr Treat Options Neurol. 2019;21:6.

Article  PubMed  Google Scholar 

Vogelbaum MA, Brown PD, Messersmith H, Brastianos PK, Burri S, Cahill D, et al. Treatment for brain metastases: ASCO-SNO-ASTRO guideline. J Clin Oncol. 2022;40:492–516.

Article  PubMed  CAS  Google Scholar 

Sawrie SM, Guthrie BL, Spencer SA, Nordal RA, Meredith RF, Markert JM, et al. Predictors of distant brain recurrence for patients with newly diagnosed brain metastases treated with stereotactic radiosurgery alone. Int J Radiat Oncol Biol Phys. 2008;70:181–6.

Article  PubMed  Google Scholar 

Mizuno T, Takada K, Hasegawa T, Yoshida T, Murotani K, Kobayashi H, et al. Comparison between stereotactic radiosurgery and whole-brain radiotherapy for 10–20 brain metastases from non-small cell lung cancer. Mol Clin Oncol. 2019;10:560–6.

PubMed  PubMed Central  CAS  Google Scholar 

Mizumatsu S, Monje ML, Morhardt DR, Rola R, Palmer TD, Fike JR. Extreme sensitivity of adult neurogenesis to low doses of X-irradiation. Cancer Res. 2003;63:4021–7.

PubMed  CAS  Google Scholar 

Monje ML, Mizumatsu S, Fike JR, Palmer TD. Irradiation induces neural precursor-cell dysfunction. Nat Med. 2002;8:955–62.

Article  PubMed  CAS  Google Scholar 

Kazda T, Jancalek R, Pospisil P, Sevela O, Prochazka T, Vrzal M, et al. Why and how to spare the hippocampus during brain radiotherapy: the developing role of hippocampal avoidance in cranial radiotherapy. Radiat Oncol. 2014;9:139.

Article  PubMed  PubMed Central  Google Scholar 

Popp I, Rau S, Hintz M, Schneider J, Bilger A, Fennell JT, et al. Hippocampus-avoidance whole-brain radiation therapy with a simultaneous integrated boost for multiple brain metastases. Cancer. 2020;126:2694–703.

Article  PubMed  CAS  Google Scholar 

Hartgerink D, Bruynzeel A, Eekers D, Swinnen A, Hurkmans C, Wiggenraad R, et al. A Dutch phase III randomized multicenter trial: whole brain radiotherapy versus stereotactic radiotherapy for 4–10 brain metastases. Neurooncol Adv. 2021;3:vdab021.

PubMed  PubMed Central  Google Scholar 

Li J, Ludmir EB, Wang Y, Guha-Thakurta N, McAleer MF, Settle SH Jr, et al. Stereotactic radiosurgery versus whole-brain radiation therapy for patients with 4–15 brain metastases: a phase III randomized controlled trial. Int J Radiat Oncol Biol Phys. 2020;108:21–2.

Article  Google Scholar 

Gondi V, Pugh SL, Tome WA, Caine C, Corn B, Kanner A, et al. Preservation of memory with conformal avoidance of the hippocampal neural stem-cell compartment during whole-brain radiotherapy for brain metastases (RTOG 0933): a phase II multi-institutional trial. J Clin Oncol. 2014;32:3810–6.

Article  PubMed  PubMed Central  Google Scholar 

Brown PD, Gondi V, Pugh S, Tome WA, Wefel JS, Armstrong TS, et al. Hippocampal avoidance during whole-brain radiotherapy plus memantine for patients with brain metastases: phase III trial NRG oncology CC001. J Clin Oncol. 2020;38:1019–29.

Article  PubMed  PubMed Central  Google Scholar 

Rodríguezde Dios N, Couñago F, Murcia-Mejía M, Rico-Oses M, Calvo-Crespo P, Samper P, et al. Randomized phase III trial of prophylactic cranial irradiation with orwithout hippocampal avoidance for small-cell lung cancer (PREMER): aGICOR-GOECP-SEOR study. J Clin Oncol. 2021;39:3118–27.

Article  Google Scholar 

Grosu A-L, Frings L, Bentsalo I, Oehlke O, Brenner F, Bilger A, et al. Whole-brain irradiation with hippocampal sparing and dose escalation on metastases: neurocognitive testing and biological imaging (HIPPORAD)—a phase II prospective randomized multicenter trial (NOA-14, ARO 2015-3, DKTK-ROG). BMC Cancer. 2020;20:532.

Article  PubMed  PubMed Central  Google Scholar 

Prescribing R. Intensity-modulated radiation therapy (IMRT): contents. J ICRU. 2010;10:1–3.

Article  Google Scholar 

Riet AV, Mak ACA, Moerland MA, Elders LH, van der Zee W. A conformation number to quantify the degree of conformality in brachytherapy and external beam irradiation: application to the prostate. Int J Radiat Oncol Biol Phys. 1997. https://doi.org/10.1016/s0360-3016(96)00601-3.

Article  Google Scholar 

Andrews DW, Scott CB, Sperduto PW, Flanders AE, Gaspar LE, Schell MC, et al. Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial. Lancet. 2004;363:1665–72.

Article  PubMed  Google Scholar 

Sperduto PW, Shanley R, Luo X, Andrews D, Werner-Wasik M, Valicenti R, et al. Secondary analysis of RTOG 9508, a phase 3 randomized trial of whole-brain radiation therapy versus WBRT plus stereotactic radiosurgery in patients with 1–3 brain metastases; poststratified by the graded prognostic assessment (GPA). Int J Radiat Oncol Biol Phys. 2014;90:526–31.

Article  PubMed  PubMed Central  Google Scholar 

Westover KD, Mendel JT, Dan T, Kumar K, Gao A, Pulipparacharuv S, et al. Phase II trial of hippocampal-sparing whole brain irradiation with simultaneous integrated boost for metastatic cancer. Neuro Oncol. 2020;22:1831–9.

Article  PubMed  PubMed Central  Google Scholar 

Belderbos JSA, De Ruysscher DKM, De Jaeger K, Koppe F, Lambrecht MLF, Lievens YN, et al. Phase 3 randomized trial of prophylactic cranial irradiation with or without hippocampus avoidance in SCLC (NCT01780675). J Thorac Oncol. 2021;16:840–9.

Article  PubMed  Google Scholar 

Wolfson AH, Bae K, Komaki R, Meyers C, Movsas B, Le Pechoux C, et al. Primary analysis of a phase II randomized trial radiation therapy oncology group (RTOG) 0212: impact of different total doses and schedules of prophylactic cranial irradiation on chronic neurotoxicity and quality of life for patients with limited-disease small-cell lung cancer. Int J Radiat Oncol Biol Phys. 2011;81:77–84.

Article  PubMed  Google Scholar 

Li T, Irmen P, Liu H, Shi W, Alonso-Basanta M, Zou W, et al. Dosimetric performance and planning/delivery efficiency of a dual-layer stacked and staggered MLC on treating multiple small targets: a planning study based on single-isocenter multi-target stereotactic radiosurgery (SRS) to brain metastases. Front Oncol. 2019;9:7.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Yokoyama K, Kurosaki H, Oyoshi H, Miura K, Utsumi N. Plan quality comparison between hippocampus-sparing whole-brain radiotherapy treated with Halcyon and tomotherapy intensity-modulated radiotherapy. Technol Cancer Res Treat. 2022;21:15330338221108528.

Article  PubMed  PubMed Central  Google Scholar 

Popp I, Grosu AL, Fennell JT, Fischer M, Baltas D, Wiehle R. Optimization of hippocampus sparing during whole brain radiation therapy with simultaneous integrated boost-tutorial and efficacy of complete directional hippocampal blocking. Strahlenther Onkol. 2022;198:537–46.

Article  PubMed  PubMed Central  Google Scholar 

Hsu F, Carolan H, Nichol A, Cao F, Nuraney N, Lee R, et al. Whole brain radiotherapy with hippocampal avoidance and simultaneous integrated boost for 1–3 brain metastases: a feasibility study using volumetric modulated arc therapy. Int J Radiat Oncol Biol Phys. 2010;76:1480–5.

Article  PubMed  Google Scholar 

Usui K, Isobe A, Hara N, Muroi T, Sajiki O, Ogawa K, et al. Development of a rotational set-up correction device for stereotactic head radiation therapy: a performance evaluation. J Appl Clin Med Phys. 2019;20:206–12.

Article  PubMed  PubMed Central  Google Scholar 

Sauer O, Wegener S, Schindhelm R. PO-1737 design of a rotatable head fixation for cranial stereotactic treatments. Radiother Oncol. 2021;161:S1460-1.

Article  Google Scholar